Jeff is a veteran of the pharmaceutical industry with 40 years of leadership experience in developing and commercializing new medical therapies. He has invented products leading to significant improvements in patient care and has numerous patents issued by the USPTO in healthcare. He has a track record of success in developing new companies from start-up, through IPO and M&A exits.
Jeff Keyser, Ph.D., RPh, JD
Co-Founder, President & COO
Back to Home
- Co-founder and COO at ZS Pharma, acquired by Astra Zeneca in 2015 for $2.7 billion.
- Inventor of the Mucinex product line for Adams Respiratory Therapeutics. He developed and executed the R&D and Regulatory strategy as VP of Development and Regulatory Affairs, which subsequently was acquired by Reckitt Benckiser for $2.3 billion in 2007.
- Senior positions at Encysive Pharmaceuticals, Medeva Americas, Marion Merrell Dow and Abbott Laboratories. He is currently serving as the Chairman of the Board for Lantern Pharma.